Tools

European drugmakers are better than their U.S. counterparts in ensuring medicines reach people in poor countries, with Britain’s GlaxoSmithKline Plc… »   

U.S. drug regulators are concerned about life-threatening complications in children taking Amgen Inc’s drug Enbrel for psoriasis and other conditions,… »   

The U.S. Food and Drug Administration failed to review on time nearly half the applications from generic drug makers seeking… »   

Thirty percent of rheumatoid arthritis patients who failed to respond adequately to anti-TNF therapy achieved remission from their disease when… »   

Health care plans that restrict members’ access to certain arthritis medications due to cost concerns may actually wind up spending… »   

Paris, France, Friday 13 June 2008: New data presented today at EULAR 2008, the Annual Congress of the European League… »   

A nearly 7-year study of the effect of intensive blood sugar control with rosiglitazone (Avandia, GlaxoSmithKline) on the progression… »   

An experimental treatment for rheumatoid arthritis being developed by Johnson & Johnson and Schering-Plough Corp appeared to be effective… »   

Roche Holding AG’s MabThera was more effective in treating rheumatoid arthritis (RA) patients than other drugs with a more traditional… »   

An experimental injectable type 2 diabetes drug being developed by Sanofi-Aventis SA was well tolerated and significantly improved blood sugar… »